NEUROLOGY 1993;43:65
© 1993 American Academy of Neurology
Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure
A. Pujol, MD,
J. Pujol, MD,
F. Graus, MD,
A. Rimola, MD,
J. Peri, MD,
J. M. Mercader, MD,
J. C. García-Pagan, MD,
J. Bosch, MD,
J. Rodés, MD and
E. Tolosa, MD
Department of Neurology (Drs. A. Pujol, Graus, and Tolosa), Liver Unit (Drs. Rimola, García-Pagan, Bosch, and Rodés), and Department of Radiology (Drs. Peri and Mercader), Hospital Clínic i Provincial, University of Barcelona; and the Department of Neurology (Dr. J. Pujol), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Hyperintense globus pallidus on T1 weighted MRI is present in most patients with advanced liver disease. We evaluated the relationship between the signal intensity of the globus pallidus and clinical or laboratory data of 77 patients eligible for liver transplantation. There was a significant correlation between the intensity of the signal and the Child-Pugh score (as indication of severity of liver disease), presence of postural tremor, previous episodes of variceal bleeding or hepatic encephalopathy, prothrombin activity, serum aspartate and alanine aminotransferase, bilirubin, and the indocyanine green (ICG) hepatic clearance, a very sensitive marker of liver function. The multivariate analysis disclosed that the ICG hepatic clearance and previous episodes of variceal bleeding were independently associated with the signal intensity in the globus pallidus. MRI repeated in 21 patients 10 to 20 months after transplant showed a disappearance of the lesion in all cases. We conclude that the hyperintense globus pallidus is secondary to the severity of the liver disease, and is reversible when liver function returns to normal.
Address correspondence and reprint requests to Dr. Francesc Graus, Department of Neurology, Hospital Clínic i Provincial, Villarroel 170, 08036 Barcelona, Spain.
Received April 7,1992. Accepted for publication in final form June 9, 1992.
This article has been cited by other articles:

|
 |

|
 |
 
R. Arya, S. Gulati, and S. Deopujari
Management of hepatic encephalopathy in children
Postgrad. Med. J.,
January 1, 2010;
86(1011):
34 - 41.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-L. Long, X.-R. Li, Z.-K. Huang, Y.-M. Jiang, S. X. Fu, and W. Zheng
Relationship Between Changes in Brain MRI and 1H-MRS, Severity of Chronic Liver Damage, and Recovery After Liver Transplantation
Exp Biol Med,
September 1, 2009;
234(9):
1075 - 1085.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rovira, J. Alonso, and J. Cordoba
MR Imaging Findings in Hepatic Encephalopathy
AJNR Am. J. Neuroradiol.,
October 1, 2008;
29(9):
1612 - 1621.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Stepens, I. Logina, V. Liguts, P. Aldins, I. Eksteina, A. Platkajis, I. Martinsone, E. Terauds, B. Rozentale, and M. Donaghy
A Parkinsonian Syndrome in Methcathinone Users and the Role of Manganese
N. Engl. J. Med.,
March 6, 2008;
358(10):
1009 - 1017.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Klos, J. E. Ahlskog, N. Kumar, S. Cambern, J. Butz, M. Burritt, R. D. Fealey, C. T. Cowl, J. E. Parisi, and K. A. Josephs
Brain metal concentrations in chronic liver failure patients with pallidal T1 MRI hyperintensity
Neurology,
December 12, 2006;
67(11):
1984 - 1989.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A J Wills, D S N A Pengiran Tengah, and G K T Holmes
The neurology of enteric disease
J. Neurol. Neurosurg. Psychiatry,
July 1, 2006;
77(7):
805 - 810.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T.J. Kim, I.O. Kim, W.S. Kim, J.E. Cheon, S.G. Moon, J.W. Kwon, J.K. Seo, and K.M. Yeon
MR Imaging of the Brain in Wilson Disease of Childhood: Findings Before and After Treatment with Clinical Correlation
AJNR Am. J. Neuroradiol.,
June 1, 2006;
27(6):
1373 - 1378.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Zucco, P. Amodio, and A. Gatta
Olfactory Deficits in Patients Affected by Minimal Hepatic Encephalopathy: A Pilot Study
Chem Senses,
March 1, 2006;
31(3):
273 - 278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Klos, J. E. Ahlskog, K. A. Josephs, R. D. Fealey, C. T. Cowl, and N. Kumar
Neurologic Spectrum of Chronic Liver Failure and Basal Ganglia T1 Hyperintensity on Magnetic Resonance Imaging: Probable Manganese Neurotoxicity
Arch Neurol,
September 1, 2005;
62(9):
1385 - 1390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lewis and P.D. Howdle
The neurology of liver failure
QJM,
September 1, 2003;
96(9):
623 - 633.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. R. Burkhard, J. Delavelle, R. Du Pasquier, and L. Spahr
Chronic Parkinsonism Associated With Cirrhosis: A Distinct Subset of Acquired Hepatocerebral Degeneration
Arch Neurol,
April 1, 2003;
60(4):
521 - 528.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Shulman, A. Minagar, and W. J. Weiner
Reversal of parkinsonism following liver transplantation
Neurology,
February 11, 2003;
60(3):
519 - 519.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Timmermann, J. Gross, G. Kircheis, D. Haussinger, and A. Schnitzler
Cortical origin of mini-asterixis in hepatic encephalopathy
Neurology,
January 22, 2002;
58(2):
295 - 298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Naegele, W. Grodd, R. Viebahn, U. Seeger, U. Klose, D. Seitz, S. Kaiser, I. Mader, J. Mayer, W. Lauchart, et al.
MR Imaging and
Radiology,
September 1, 2000;
216(3):
683 - 691.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E. Genovese, M. Maghnie, G. Maggiore, C. Tinelli, F. Lizzoli, C. D. Giacomo, S. Pozza, and R. Campani
MR Imaging of CNS Involvement in Children Affected by Chronic Liver Disease
AJNR Am. J. Neuroradiol.,
May 1, 2000;
21(5):
845 - 851.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. A. Wardle, A. Forbes, N. B. Roberts, A.V. Jawhari, and A. Shenkin
Hypermanganesemia in Long-Term Intravenous Nutrition and Chronic Liver Disease
JPEN J Parenter Enteral Nutr,
November 1, 1999;
23(6):
350 - 355.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E A Jones and K Weissenborn
Neurology and the liver
J. Neurol. Neurosurg. Psychiatry,
September 1, 1997;
63(3):
279 - 293.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Riordan and R. Williams
Treatment of Hepatic Encephalopathy
N. Engl. J. Med.,
August 14, 1997;
337(7):
473 - 479.
[Full Text]
[PDF]
|
 |
|
|